Drugs / MVA-mBN294B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04752644 | Feb → Jun 2021 | respiratory syncytial virus infectious disease | Bavarian Nordic | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-mBN294B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04752644 ↗ |